Payments to Acquire Property, Plant, and Equipment of INOVIO PHARMACEUTICALS, INC. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
INOVIO PHARMACEUTICALS, INC. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • INOVIO PHARMACEUTICALS, INC. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $59,373, a 67% increase year-over-year.
  • INOVIO PHARMACEUTICALS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $285,698, a 41% decline from 2024.
  • INOVIO PHARMACEUTICALS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $487,832, a 52% increase from 2023.
  • INOVIO PHARMACEUTICALS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $320,898, a 67% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

INOVIO PHARMACEUTICALS, INC. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $285,698 -$202,134 -41% 01 Jan 2025 31 Dec 2025 10-K 12 Mar 2026 2025 FY
2024 $487,832 +$166,934 +52% 01 Jan 2024 31 Dec 2024 10-K 12 Mar 2026 2025 FY
2023 $320,898 -$648,255 -67% 01 Jan 2023 31 Dec 2023 10-K 18 Mar 2025 2024 FY
2022 $969,153 -$261,853 -21% 01 Jan 2022 31 Dec 2022 10-K 06 Mar 2024 2023 FY
2021 $1,231,006 -$289,659 -19% 01 Jan 2021 31 Dec 2021 10-K 06 Mar 2024 2023 FY
2020 $1,520,665 +$532,739 +54% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2019 $987,926 -$1,097,096 -53% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 $2,085,022 -$8,208,880 -80% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021 2020 FY
2017 $10,293,902 +$7,555,432 +276% 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2020 2019 FY
2016 $2,738,470 -$43,074 -1.5% 01 Jan 2016 31 Dec 2016 10-K 12 Mar 2019 2018 FY
2015 $2,781,544 +$1,401,564 +102% 01 Jan 2015 31 Dec 2015 10-K 14 Mar 2018 2017 FY
2014 $1,379,980 +$1,203,055 +680% 01 Jan 2014 31 Dec 2014 10-K 15 Mar 2017 2016 FY
2013 $176,925 -$64,061 -27% 01 Jan 2013 31 Dec 2013 10-K 14 Mar 2016 2015 FY
2012 $240,986 +$79,799 +50% 01 Jan 2012 31 Dec 2012 10-K 16 Mar 2015 2014 FY
2011 $161,187 -$20,462 -11% 01 Jan 2011 31 Dec 2011 10-K 17 Mar 2014 2013 FY
2010 $181,649 01 Jan 2010 31 Dec 2010 10-K 18 Mar 2013 2012 FY

INOVIO PHARMACEUTICALS, INC. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $59,373 +$23,795 +67% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q1 2024 $35,578 -$261,405 -88% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q1 2023 $296,983 +$296,983 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q1 2022 $0 -$210,824 -100% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q1 2021 $210,824 +$69,872 +50% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q1 2020 $140,952 -$517,779 -79% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q1 2019 $658,731 -$494,734 -43% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q1 2018 $1,153,465 +$364,208 +46% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q1 2017 $789,257 +$108,116 +16% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018 2018 Q1
Q1 2016 $681,141 +$154,282 +29% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q1 2015 $526,859 +$345,099 +190% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016 2016 Q1
Q1 2014 $181,760 +$142,051 +358% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015 2015 Q1
Q1 2013 $39,709 -$56,624 -59% 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014 2014 Q1
Q1 2012 $96,333 +$36,536 +61% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013 2013 Q1
Q1 2011 $59,797 01 Jan 2011 31 Mar 2011 10-Q 09 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.